Recognized standard

TS 21362 First edition 2018-06

FDA recognition 18-16 · ISO · Nanotechnology

Key facts

Recognition number 18-16
Designation TS 21362 First edition 2018-06
Title Nanotechnologies - Analysis of nano-objects using asymmetrical-flow and centrifugal field-flow fractionation
Standards developer International Organization for Standardization
Specialty area Nanotechnology
Date of entry Jul 6, 2020
Scope (excerpt) This document identifies parameters and conditions, as part of an integrated measurement system, necessary to develop and validate methods for the application of asymmetrical-flow and centrifugal field-flow fractionation to the analysis of nano-objects and their aggregates and agglomerates dispersed…

At a glance

  • None Product codes
  • 1–9 FDA guidance documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA-recognized consensus standards

The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.

Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date:

Browse all FDA-recognized consensus standards